Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

LGBTQ+

Church Pharmacy increases productivity

Video of how Church pharmacy moved from a traditional to an automated  set up and increased accuracy to 99%

Kardex

- PMLiVE

Date set for EU antitrust regulators to decide on Pfizer’s $43bn Seagen acquisition

The proposed transaction would mark a significant boost to the US pharma’s oncology pipeline

EU flag

EC approves Otsuka and Astex’s Inaqovi for acute myeloid leukaemia

Inaqovi is the first oral hypomethylating agent approved for this patient population

- PMLiVE

CSL Seqirus highlights impact of flu vaccines on reducing strain on healthcare resources

Flu vaccines for older adults in France could reduce hospitalisations by up to 30%

- PMLiVE

Harnessing innovation to change the future of chronic diseases in Europe

By Stefan Woxström

- PMLiVE

Moderna’s XBB.1.5-adapted COVID-19 vaccine receives MHRA approval

The vaccine has been updated to target the currently circulating XBB.1.5 Omicron variant

- PMLiVE

Almirall receives CHMP recommendation for lebrikizumab in atopic dermatitis

The drug has been recommended as a treatment option for adult and adolescent patients

- PMLiVE

GSK’s Ojjaara receives FDA approval to treat myelofibrosis patients with anaemia

Myelofibrosis is a rare blood cancer affecting approximately 25,000 patients in the US

- PMLiVE

NHS bookings for COVID-19 vaccinations open as winter programme starts early

Millions of people in England are now eligible to receive flu and COVID-19 vaccines

- PMLiVE

Clinigen launches educational programme for rare disease patients and organisations

The NaviGATE programme will aim to empower patients and provide navigational support

- PMLiVE

PM Society announces 2023 Digital Award winners

OPEN Health takes three Golds while Astellas Pharma UK tops client leader board

- PMLiVE

Point.1 – HCP data with purpose and perception

By Phil Streit and Sarah Price

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links